Investors / United States / ShangBay Capital
ShangBay Capital
Venture capital · Palo Alto, CA, United States · North America
ShangBay Capital is a venture capital firm based in Palo Alto that makes venture equity investments in medical devices, biotechnology, and healthcare technology. It works with founders to commercialize products, navigate FDA regulatory approval, and expand into U.S. and global markets.
Invests inHealthcare & Biotech
In its own wordsmedical devicesbiotechhealthcarefdacommercialization
Your fit with ShangBay Capital
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsShangBay Capital lists 54 checked portfolio companies on its own site and is named in 3 funding rounds, 1 of them as lead. Its most frequent entry is Series B, 67% of the companies with a known first round. Its largest themes are Healthcare & Biotech (98%) and AI & Machine Learning (2%). 84% of its companies are based in United States. It invests most often alongside Agent Capital, Asahi Kasei Ventures and RA Capital.
Counts come from funding rounds that name ShangBay Capital, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not ShangBay Capital's whole history. Rounds on record name 3 companies; its own site lists 54. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShangBay Capital does not state its stages on its site, so only what it does is shown.
Show as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 33% |
| Series B | 67% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 1 | 0 |
| '26 | 2 | 1 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 86th | 54 companies |
| Recent activity | 69th | 2 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 59th | 4% of companies confirmed by a round |
| Sector focus | 97th | 98% in its largest sector |
| Reach | 78th | 5 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Agent Capital | 3 |
| Asahi Kasei Ventures | 3 |
| RA Capital | 3 |
| StartX | 3 |
| Actions Capital | 2 |
| Camford Capital | 2 |
| Catalio Capital Management | 2 |
| Elevage Medical Technologies | 2 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers54100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 98% | 15% |
| AI & Machine Learning | 2% | 18% |
Co-investor network
who it backs companies with, and who they back togetherCompare ShangBay Capital head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with ShangBay Capital| Date | Company | Stage |
|---|---|---|
| 29 Jul 2026 | Series A Led | |
| 27 Apr 2026 | Series B | |
| 11 Aug 2025 | Series B |
Round details for ShangBay Capital
Amounts, full round histories and every co-investor in ShangBay Capital's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
54 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Abcuro develops therapies for autoimmune diseases and cancer. | Healthcare & Biotech | Portfolio page | ||
| Alleviant Medical is currently evaluating interatrial shunt therapy in heart failure patients through clinical trials. | Healthcare & Biotech | Portfolio page | ||
| Aqua Medical develops a vapor ablation platform for treating type 2 diabetes and other gastrointestinal diseases through an outpatient procedure. | Healthcare & Biotech | Portfolio page | ||
| ARANZ Medical provides a wound care workflow platform called Silhouette that delivers effective tracking, charting, and reporting of wound healing. | Healthcare & Biotech | Portfolio page | ||
| Avation Medical develops and offers a wearable at-home treatment for overactive bladder | Healthcare & Biotech | Portfolio page | ||
| Brius Technologies Inc produces and markets hidden braces for teeth straightening | Healthcare & Biotech | Portfolio page | ||
| Ceribell develops and provides point-of-care EEG products for intensive care units, emergency departments, and neurology | Healthcare & Biotech | Portfolio page | ||
| Chimera Bioengineering creates treatments centered around controlling cancer at the cell level using CAR-T Cell Therapy | Healthcare & Biotech | Portfolio page | ||
| Portfolio page | ||||
| Contraline is a company developing investigational male contraceptive products, including a topical gel and a reversible implant. | Healthcare & Biotech | Portfolio page | ||
| EpimAb Biotherapeutics develops innovative biopharmaceuticals using its proprietary bispecific antibody technology platform FIT-Ig | Healthcare & Biotech | Portfolio page | ||
| Evident Vascular is transforming intravascular ultrasound imaging technology for peripheral vascular interventions. | Healthcare & Biotech | Portfolio page | ||
| FemDx Medsystems develops an ultra-miniature FDA-cleared endoscope and AI platform for collecting cells from the fallopian tube to detect ovarian cancer and other gynecologic diseases. | Healthcare & BiotechAI & Machine Learning | Portfolio page | ||
| Flare Therapeutics designs small molecules to treat disease, particularly cancer, by regaining transcriptional control hijacked by cancer cells. | Healthcare & Biotech | Portfolio page | ||
| Fluid Biomed is advancing the first-of-its-kind polymer-based flow-diverting stent through clinical investigation to treat brain aneurysms. | Healthcare & Biotech | Portfolio page | ||
| Huma.AI provides predictive site intelligence to help protect clinical trial timelines from delays | Healthcare & Biotech | Portfolio page | ||
| IgGenix is a clinical-stage antibody discovery and development company that solves allergies and other immunological diseases. | Healthcare & Biotech | Portfolio page | ||
| Immune-Onc Therapeutics is a clinical-stage biopharmaceutical company advancing novel therapies that target myeloid cells | Healthcare & Biotech | Portfolio page | ||
| Inquis Medical develops and commercializes medical devices, including the AVENTUS Precision Thrombectomy System, for treating vascular conditions such as pulmonary embolism. | Healthcare & Biotech | Portfolio page | ||
| Laplace Interventional is developing a Transcatheter tricuspid valve replacement system | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- shangbaycapital.com
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 11 Aug 2025
- Companies checked
- 54
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get ShangBay Capital's profile as data
Pull ShangBay Capital's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/shangbaycapital.com
# also
GET /v1/firms/shangbaycapital.com/portfolio
GET /v1/firms/shangbaycapital.com/coinvestors
GET /v1/firms/shangbaycapital.com/news